ARS Pharmaceuticals, Inc Earnings

The next earnings date for ARS Pharmaceuticals, Inc is August 6, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of ARS Pharmaceuticals, Inc Earnings

Report DateEstimated Earnings Per Share
11/06/2025$-0.40
08/06/2025$-0.46

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

ARS Pharmaceuticals, Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/07/2025Before Market$-0.35-218.18%
03/19/2025Before Market------
11/07/2024Before Market$-0.20-33.33%
08/06/2024After Market$-0.13-8.33%
05/09/2024After Market$-0.110.00%
03/21/2024After Market$-0.0750.00%
11/09/2023After Market$-0.1611.11%
08/10/2023After Market$-0.18-5.88%
05/15/2023Before Market$-0.165.88%
03/23/2023After Market$0.77692.31%
11/02/2022After Market$-0.50-42.86%
08/11/2022After Market$-0.55-14.58%
05/12/2022After Market$-0.70-29.63%
03/31/2022After Market$-0.674.29%
11/10/2021After Market$-0.652.99%
08/12/2021After Market$-0.70-32.08%
05/13/2021After Market$-0.54-54.29%
03/29/2021After Market$-1.37-179.59%
11/10/2020After Market$-0.70---

More About ARS Pharmaceuticals, Inc

Website
https://ars-pharma.com
Country
USA
Full Time Employees
155

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.

“ARS Pharmaceuticals, Inc Earnings” Can Refer to the ARS Pharmaceuticals, Inc Earnings Date

Some people say “ARS Pharmaceuticals, Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my ARS Pharmaceuticals, Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning ARS Pharmaceuticals, Inc Stock on the Earnings Date

If you own ARS Pharmaceuticals, Inc stock (SPRY) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for ARS Pharmaceuticals, Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading ARS Pharmaceuticals, Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More ARS Pharmaceuticals, Inc Earnings

You can contact us any time if you would like to ask questions about ARS Pharmaceuticals, Inc earnings or anything else related to the stock market.